Caleb Ho
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Autoimmune and Inflammatory Disorders Research
- Acute Myeloid Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Hematology 25
- Multiple Myeloma Research and Treatments 15
- Acute Myeloid Leukemia Research 8
-
- Lymphoma Diagnosis and Treatment 12
- Co-authors
- Stewart Shuman (2 shared papers)Yi Pei (1 shared paper)Mina L. Xu (2 shared papers)Maria Arcila (9 shared papers)Fangyong Li (1 shared paper)Nikolai Alexandrovich Podoltsev (1 shared paper)Xiaopan Yao (1 shared paper)Ryma Benayed (3 shared papers)
- Journals
- Journal of Molecular Diagnostics (7 papers)Blood (5 papers)Blood Advances (4 papers)American Journal of Clinical Pathology (2 papers)The Lancet Haematology (2 papers)
- Partner nations
- United StatesNorwayAustralia
In The Last Decade
Caleb Ho
45 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 58
- Hematology 558
- Pathology and Forensic Medicine 206
- Virology 27
- Genetics 48
- Oncology 118
Countries citing papers authored by Caleb Ho
This map shows the geographic impact of Caleb Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caleb Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caleb Ho more than expected).
Fields of papers citing papers by Caleb Ho
This network shows the impact of papers produced by Caleb Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caleb Ho. The network helps show where Caleb Ho may publish in the future.
Co-authors
The 25 scholars most cited alongside Caleb Ho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 137 | |
| 2 | 2013 | 116 | |
| 3 | 2020 | 99 | |
| 4 | 2021 | 90 | |
| 5 | 2021 | 78 | |
| 6 | 1998 | 72 | |
| 7 | 2018 | 68 | |
| 8 | 2018 | 58 | |
| 9 | 2019 | 55 | |
| 10 | 1996 | 39 | |
| 11 | 2020 | 39 | |
| 12 | 2020 | 36 | |
| 13 | 2021 | 32 | |
| 14 | 1999 | 31 | |
| 15 | 2016 | 29 | |
| 16 | 2019 | 28 | |
| 17 | 2020 | 28 | |
| 18 | 2016 | 27 | |
| 19 | 2019 | 27 | |
| 20 | 2023 | 27 |
About Caleb Ho
Caleb Ho is a scholar working on Hematology, Pathology and Forensic Medicine, Genetics, Cancer Research and Virology, having authored 50 papers that have together received 1.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (15 papers), Lymphoma Diagnosis and Treatment (12 papers), Acute Myeloid Leukemia Research (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Salivary Gland Tumors Diagnosis and Treatment (2 papers), RNA Research and Splicing (2 papers), Salivary Gland Disorders and Functions (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Hematology (558 citations), Pathology and Forensic Medicine (206 citations), Virology (27 citations), Genetics (48 citations) and Oncology (118 citations). Caleb Ho has collaborated with scholars based in United States, Norway and Australia. Frequent co-authors include Stewart Shuman, Yi Pei, Mina L. Xu, Maria Arcila, Fangyong Li, Nikolai Alexandrovich Podoltsev, Xiaopan Yao, Ryma Benayed, Khédoudja Nafa and Ola Landgren. Their work appears in journals such as Journal of Molecular Diagnostics, Blood, Blood Advances, American Journal of Clinical Pathology and The Lancet Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.